logo

For the Inventor, By the Inventor

Miaoli County, Taiwan

National Health Research Institutes


USPTO Granted Patents = 181



Forward Citations = 448

Loading Chart...
Loading Chart...

329 inventors (with patents filed for the assignee):

goldMedal Yu-Sheng Chao (30 out of 31 patents)

silverMedal Pele Choi-Sing Chong (18 out of 18 patents)

bronzeMedal Chih-Hsiang Leng (16 out of 17 patents)

4.  Hsing-Pang Hsieh (16 out of 19 patents)

5.  Chiung-Tong Chen (15 out of 15 patents)

6.  Hsin-Wei Chen (14 out of 15 patents)

7.  Shih-Jen Liu (12 out of 12 patents)

8.  Kak-Shan Shia (12 out of 14 patents)

9.  Tsu-An Hsu (12 out of 17 patents)

10.  Jang-Yang Chang (11 out of 13 patents)

11.  Chung-Shi Yang (11 out of 14 patents)

12.  Jyh-Haur Chern (10 out of 10 patents)

13.  Jing-Ping Liou (8 out of 23 patents)

14.  Chuan Shih (8 out of 38 patents)

15.  Ko-Jiunn Liu (8 out of 15 patents)


Core Competencies:
D-Amino Acid Oxidase Inhibitors
Pharmacological Induction
Therapeutic Ultrasonic Devices
Coronary Artery Blockage Prediction
PH-Responsive Hydrogel
Humanized Antibodies
Cancer Immunotherapy
Biodegradable Nanodandelions
Microfluidic Devices
Neurotensin Receptor Antibodies
Vaccine Production
Nerve Regeneration

181 patents:

1. 12312326 - Substituted benzimidazole derivatives as D-amino acid oxidase (DAAO) inhibitors (2025-05-27),
2. 12246021 - Compounds for uses in pharmacological induction of HBF for treatment of sickle cell disease and ß-thalassemia (2025-03-11),
3. 12239331 - Therapeutic ultrasonic device and the use thereof (2025-03-04),
4. 12226218 - Electronic device and method for predicting blockage of coronary artery (2025-02-18),
5. 12220241 - Electronic device and method for selecting feature of electrocardiogram (2025-02-11),
6. 12208115 - PH-responsive hydrogel and manufacturing method thereof (2025-01-28),
7. 12202825 - Pyrimidine compounds and use thereof (2025-01-21),
8. 12129242 - Substituted benzimidazole derivatives as D-amino acid oxidase (DAAO) inhibitors (2024-10-29),
9. 12091454 - Humanized anti-human neurotensin receptor 1 antibodies and their uses (2024-09-17),
10. 12012400 - Method of the preparation of fused multicyclic compounds (2024-06-18),
11. 12011712 - High-efficiency single-cell collection method (2024-06-18),
12. 11957667 - Inhibitors of positive strand RNA viruses (2024-04-16),
13. 11938546 - Precision control of large-scale green synthesis of biodegradable gold nanodandelions as potential radiotheranostics (2024-03-26),
14. 11898147 - CpG-oligodeoxynucleotide compounds in combination with immune modulators for cancer immunotherapy (2024-02-13),
15. 11878986 - Poly heterocyclic conjugates and their pharmaceutical uses (2024-01-23),
The National Health Research Institutes (NHRI) is a non-profit research organization established in Taiwan. They conduct biomedical and public health research, aiming to improve the health and well-being of the population. NHRI focuses on enhancing medical technology, developing innovative therapies, and contributing to preventive medicine. Through collaborations with universities, medical centers, and international institutions, they strive to advance scientific knowledge and promote healthcare innovations for the benefit of society.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 23 2025

...
181 Patents

#1 in Miaoli County

#139 in Taiwan

#4,472 in the World

...
Miaoli County, Taiwan

National Health Research Institutes

Forward Citations = 448

329 inventors:

goldMedal Yu-Sheng Chao (30 out of 31 patents)

silverMedal Pele Choi-Sing Chong (18 out of 18 patents)

bronzeMedal Chih-Hsiang Leng (16 out of 17 patents)

4.  Hsing-Pang Hsieh (16 out of 19 patents)

5.  Chiung-Tong Chen (15 out of 15 patents)

Please report any incorrect information to support@idiyas.com
Loading…